Biagio Ricciuti

Dr. Biagio Ricciuti is a thoracic medical oncologist at the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute in Boston, and an Instructor in Medicine at Harvard Medical School. His clinical and translational research focuses on the mechanisms of response and resistance to immunotherapy and targeted therapies in non-small cell lung cancer, with extensive work on immune checkpoint inhibitor outcomes and biomarkers. He has authored more than 170 peer-reviewed publications and is a recipient of young investigator awards from ASCO, IASLC, and the Society for Immunotherapy of Cancer. He is a frequent speaker at major international thoracic oncology congresses.